Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer

NCT04874025 · clinicaltrials.gov ↗

COMPLETED

Status

815

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Ibrance

Sponsor

Hospital San Carlos, Madrid